IRTC - iRhythm Technologies' CEO and President retires
iRhythm Technologies (IRTC) announces the retirement of Kevin King as president and CEO, effective Jan. 12, 2021.Under King’s leadership, iRhythm successfully completed an IPO in 2016 with its annual revenue growing from ~$5M in 2011 to projected analyst consensus of $263M in 2020.Mike Coyle will take the place of Kevin King as the company's new president and CEO. Previously, Coyle served as executive officer at Medtronic and has provided leadership consulting services to private equity, venture capital, and medical device technology firms."Mike is a proven leader in the healthcare industry with notable experience building and scaling multi-billion dollar businesses globally, particularly in cardiology," says Abhijit Talwalkar, iRhythm’s Chairman.King will continue to serve on iRhythm's board of directors and as an advisor to the business.Previously: IRhythm Tech slumps 19% on U.S. reimbursement code changes (Dec. 2)
For further details see:
iRhythm Technologies' CEO and President retires